Literature DB >> 22337175

Ectopic pregnancy mortality - Florida, 2009-2010.

.   

Abstract

Ectopic pregnancy occurs when a fertilized ovum implants on any tissue other than the endometrial lining of the uterus. Approximately 1%-2% of pregnancies in the United States are ectopic; however, these pregnancies account for 3%-4% of pregnancy-related deaths. The ectopic pregnancy mortality ratio in the United States decreased from 1.15 deaths per 100,000 live births in 1980-1984 to 0.50 in 2003-2007. During 1999-2008, the ectopic pregnancy mortality ratio in Florida was similar to the national rate, 0.6 deaths per 100,000 live births, but increased abruptly to 2.5 during 2009-2010. Florida's Pregnancy-Associated Mortality Review (PAMR) identified ectopic pregnancy deaths during 1999-2010 through its routine process of identifying all pregnancy-related deaths. A multidisciplinary investigation committee reviewed the ectopic pregnancy deaths for cause of death, risk factors, and prevention opportunities. This report summarizes the investigation results, which identified 11 ectopic pregnancy deaths from 2009-2010 and 13 deaths from the 10-year period 1999-2008. The increase in ectopic mortality appears to be associated with illicit drug use and delays in seeking health care. The findings underscore the importance of ongoing, state-based identification and review of pregnancy-related deaths. Such reviews have the potential to identify emerging causes of deaths and associated risk factors, such as ectopic pregnancy deaths among women who use illicit drugs. Efforts to prevent ectopic pregnancy deaths need to ensure early access to care, promote awareness about early pregnancy testing and ectopic pregnancy risk, and raise public awareness about substance abuse health risks, especially during pregnancy.

Entities:  

Mesh:

Year:  2012        PMID: 22337175

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  8 in total

1.  Pregnancy-Related Deaths, Florida, 1999-2012: Opportunities to Improve Maternal Outcomes.

Authors:  Leticia E Hernandez; William M Sappenfield; Karen Harris; Deborah Burch; Washington C Hill; Cheryl L Clark; Isaac Delke
Journal:  Matern Child Health J       Date:  2018-02

2.  Laparoscopic management of an abdominal pregnancy.

Authors:  Aarthi Srinivasan; Suzanne Millican
Journal:  Case Rep Obstet Gynecol       Date:  2014-11-11

3.  Spontaneous Bilateral Tubal Gestation: A Rare Case Report.

Authors:  Marwah Sheeba; Gupta Supriya
Journal:  Case Rep Obstet Gynecol       Date:  2016-07-17

4.  Pretreatment serum human chorionic gonadotropin cutoff value for medical treatment success with single-dose and multi-dose regimen of methotrexate in tubal ectopic pregnancy.

Authors:  Junhwan Kim; Young Mi Jung; Da Yong Lee; Byung Chul Jee
Journal:  Obstet Gynecol Sci       Date:  2017-01-19

5.  Ectopic pregnancy: a life-threatening gynecological emergency.

Authors:  Osaheni L Lawani; Okechukwu B Anozie; Paul O Ezeonu
Journal:  Int J Womens Health       Date:  2013-08-19

6.  Awareness about a life-threatening condition: ectopic pregnancy in a network for surveillance of severe maternal morbidity in Brazil.

Authors:  Edilberto Alves Rocha Filho; Danielly Scaranello Santana; Jose Guilherme Cecatti; Maria Laura Costa; Samira Maerrawe Haddad; Mary Angela Parpinelli; Maria Helena Sousa; Rodrigo Soares Camargo; Rodolfo Carvalho Pacagnella; Fernanda Garanhani Surita; Joao Luiz Pinto e Silva
Journal:  Biomed Res Int       Date:  2014-03-19       Impact factor: 3.411

7.  Comparison of Outcomes of IVF Cycles Between Transferred Frozen Thawed Embryos and Fresh Embryos by a 2 Year Survey.

Authors:  Ensieh Shahrokh-Tehraninejad; Zeynab Vosoog; Fatemeh Farajzadeh-Vajari
Journal:  J Reprod Infertil       Date:  2017 Oct-Dec

8.  Predictive factors of methotrexate treatment success in ectopic pregnancy: A single-center tertiary study.

Authors:  Cigdem Pulatoglu; Ozan Dogan; Alper Basbug; Aski Ellibes Kaya; Ahmet Yildiz; Osman Temizkan
Journal:  North Clin Istanb       Date:  2018-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.